Inventor · disambiguated record
Christoph Boss
Also filed as: BOSS CHRISTOPH
59 granted patents·20 pending applications·322 citations·filing 2000–2024
98Inventor score
Files withAISSAOUI HAMED24ACTELION PHARMACEUTICALS LTD23IDORSIA PHARMACEUTICALS LTD18BOLLI MARTIN3BEZENCON OLIVIER2
Top patents by PatentIndex Score
79 records- 0194US7285549B2Sulfamides and their use as endothelin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Oct 23, 2007·27 cites·5 claims
- 0292US7994336B2Azetidine compounds as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Aug 9, 2011·23 cites·15 claims
- 0391US7094781B2Sulfamides and their use as endothelin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2001·Granted Aug 22, 2006·38 cites·11 claims
- 0490US11446298B2Pyrimidine derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2018·Granted Sep 20, 2022·5 cites·20 claims
- 0589US11325899B2Benzofurane and benzothiophene derivatives as PGE2 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2018·Granted May 10, 2022·6 cites·33 claims
- 0689US8288429B22-aza-bicyclo[3.3.0]octane derivativesAISSAOUI HAMED·Filed 2008·Granted Oct 16, 2012·15 cites·13 claims
- 0789US8288411B2Pyrrolidines and piperidines as orexin receptor antagonistsAISSAOUI HAMED·Filed 2008·Granted Oct 16, 2012·14 cites·11 claims
- 0889US8067419B2Piperazines as antimalarial agentsBINKERT CHRISTOPH·Filed 2006·Granted Nov 29, 2011·13 cites·31 claims
- 0988US8236964B2Thiazolidine derivatives as orexin receptor antagonistsAISSAOUI HAMED·Filed 2008·Granted Aug 7, 2012·13 cites·17 claims
- 1088US8106215B23-aza-bicyclo[3.3.0]octane compoundsAISSAOUI HAMED·Filed 2008·Granted Jan 31, 2012·13 cites·15 claims
- 1187US9732075B2Benzimidazole-proline derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2013·Granted Aug 15, 2017·8 cites·12 claims
- 1287US8063099B2Trans-3-aza-bicyclo[3.1.0]hexane derivativesAISSAOUI HAMED·Filed 2008·Granted Nov 22, 2011·7 cites·17 claims
- 1386US8288435B22-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonistsAISSAOUI HAMED·Filed 2007·Granted Oct 16, 2012·11 cites·20 claims
- 1486US7834028B2Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Nov 16, 2010·9 cites·19 claims
- 1584US11712438B2Phenyl derivatives as PGE2 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2018·Granted Aug 1, 2023·2 cites·22 claims
- 1684US10329287B2Benzimidazole-proline derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted Jun 25, 2019·3 cites·12 claims
- 1784US9150566B22-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonistsBOLLI MARTIN·Filed 2012·Granted Oct 6, 2015·7 cites·27 claims
- 1884US8324232B24-pyrimidinesulfamide derivativeBOLLI MARTIN·Filed 2008·Granted Dec 4, 2012·13 cites·8 claims
- 1984US8003654B2N-glycinsulfonamide derivatives and uses as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Aug 23, 2011·7 cites·12 claims
- 2083US10023560B2Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonistIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted Jul 17, 2018·3 cites·13 claims
- 2183US9211279B2Proline sulfonamide derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2015·Granted Dec 15, 2015·3 cites·30 claims
- 2282US9493446B2Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Nov 15, 2016·6 cites·21 claims
- 2382US8236801B22-aza-bicyclo[2.2.1]heptane derivativesAISSAOUI HAMED·Filed 2009·Granted Aug 7, 2012·6 cites·22 claims
- 2481US9790208B2Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonistIDORSIA PHARMACEUTICALS LTD·Filed 2014·Granted Oct 17, 2017·4 cites·6 claims
- 2581US8895606B2Proline sulfonamide derivatives as orexin receptor antagonistsBOSS CHRISTOPH·Filed 2011·Granted Nov 25, 2014·5 cites·9 claims
- 2681US7868012B2Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseasesACTELION PHARMACEUTICALS LTD·Filed 2005·Granted Jan 11, 2011·4 cites·13 claims
- 2780US9000029B2Proline sulfonamide derivatives as orexin receptor antagonistsBOSS CHRISTOPH·Filed 2014·Granted Apr 7, 2015·4 cites·13 claims
- 2880US8133901B23-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitorsAISSAOUI HAMED·Filed 2007·Granted Mar 13, 2012·4 cites·10 claims
- 2979US8188082B25,6,7,8-tetrahydro-imidazo[1,5-α]pyrazine derivativesAISSAOUI HAMED·Filed 2007·Granted May 29, 2012·8 cites·11 claims
- 3078US11839613B2Pyrimidine derivatives as PGE2 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2018·Granted Dec 12, 2023·1 cites·20 claims
- 3178US9914720B2Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonistsIDORSIA PHARMACEUTICALS LTD·Filed 2014·Granted Mar 13, 2018·3 cites·12 claims
- 3278US9914721B2Use of benzimidazole-proline derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2014·Granted Mar 13, 2018·4 cites·14 claims
- 3376US9879006B2Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Jan 30, 2018·2 cites·29 claims
- 3475US9242970B2Lactam derivatives useful as orexin receptor antagonistsAISSAOUI HAMED·Filed 2011·Granted Jan 26, 2016·3 cites·12 claims
- 3575US9096595B27-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin D2 receptor modulatorsAISSAOUI HAMED·Filed 2012·Granted Aug 4, 2015·4 cites·18 claims
- 3674US11267824B2Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenaseIDORSIA PHARMACEUTICALS LTD·Filed 2018·Granted Mar 8, 2022·1 cites·14 claims
- 3772US8889688B2Piperazines as antimalarial agentsAISSAOUI HAMED·Filed 2011·Granted Nov 18, 2014·2 cites·36 claims
- 3872US7799805B2Piperidine carboxylic acid amide derivativesACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Sep 21, 2010·1 cites·9 claims
- 3972US7452896B2Pyrimidine-sulfamides and their use as endothelian receptor antagonistACTELION PHARMACEUTICALS LTD·Filed 2003·Granted Nov 18, 2008·5 cites·13 claims
- 4071US11040966B2Benzimidazole-proline derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Jun 22, 2021·0 cites·29 claims
- 4170US8575158B21-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulatorsAISSAOUI HAMED·Filed 2011·Granted Nov 5, 2013·2 cites·16 claims
- 4268US9403813B2Azetidine amide derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Aug 2, 2016·1 cites·12 claims
- 4368US9303023B2Pyrazole and imidazole derivatives useful as orexin antagonistsBOLLI MARTIN·Filed 2012·Granted Apr 5, 2016·1 cites·12 claims
- 4467US8329706B2Oxazolidinone derivativesAISSAOUI HAMED·Filed 2010·Granted Dec 11, 2012·1 cites·15 claims
- 4566US9850241B2Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Dec 26, 2017·1 cites·12 claims
- 4666US7323465B2Alkansulfonamides as endothelin antagonistsACTELION PHARMACEUTICALS LTD·Filed 2002·Granted Jan 29, 2008·2 cites·9 claims
- 4766US2021395238A1Nadph oxidase 4 inhibitorsACTELION PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 4865US7091201B2Arylalkane-sulfonamides having endothelin-antagonist activityACTELION PHARMACEUTICALS LTD·Filed 2001·Granted Aug 15, 2006·2 cites·14 claims
- 4963US11136317B2NADPH oxidase 4 inhibitorsACTELION PHARMACEUTICALS LTD·Filed 2020·Granted Oct 5, 2021·0 cites·15 claims
- 5062US7238685B2Benzo-fused heterocycles as endothelin antagonistsACTELION PHARMACEUTICALS LTD·Filed 2002·Granted Jul 3, 2007·2 cites·12 claims
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Christoph Boss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →